Number of Shares
8,240.00
Current Holdings Value*
$525,790.00
% of Portfolio
0.11%
Total Estimate Gain
$26,697.60
% of Total Estimate Gain
3.18%

Curbstone Financial Management Corp's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, Curbstone Financial Management Corp held 8,240.00 shares of Halozyme Therapeutics Inc(HALO), totaling $525,790.00. This investment constitutes 0.11% of their stock portfolio, and Curbstone Financial Management Corp now holds 0.01% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2024Q2. And since then Curbstone Financial Management Corp has made 2 purchases of HALO, at an average price of $50.98, for a total of 16,480.00 shares. In addition, there have been 1 sales at an average price of $51.19 for 8,240.00 shares. Based on historical transaction data and HALO's current price of $54.00, Curbstone Financial Management Corp's estimated gain on his HALO holdings is $26,697.60, reflecting a 3.18% gain to date.

Curbstone Financial Management Corp HALO ($54.00) Holding Chart

Curbstone Financial Management Corp HALO ($54.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1